APCOTEX INDUSTRIES LIMITE
APCOTEXIND · General/Diversified · NSE
₹529
Current Market Price
Fair Value (DCF)
₹389
Discount to FV
-26.6%
Updated just now
YieldIQ Score
63/100
Piotroski F-Score
8/9
Economic Moat
Narrow
Confidence
50%
ROE
16.3%
Debt/Equity
0.16
WACC
11.1%
Market Cap
₹2,744 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
27.1%
Return on capital employed
EV / EBITDA
8.7×
Enterprise multiple
Debt / EBITDA
0.5×
Leverage vs earnings
Interest Coverage
5.7×
EBIT covers interest
Current Ratio
1.45×
Short-term liquidity
Asset Turnover
1.43×
Revenue per ₹ of assets
Revenue CAGR (3Y)
10.1%
3-year revenue growth
Revenue CAGR (5Y)
21.4%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹529.3
Bear case
Margin of Safety —
Implied upside -126.7%
Base case
Margin of Safety -56.7%
Implied upside -36.2%
Bull case
Margin of Safety -9.1%
Implied upside -8.3%
Ratio Trends
APCOTEXIND · last 10 annual periods
ROE
16.3%
ROCE
27.1%
Operating Margin
—
Debt / Equity
0.16×
PE
16.1×
EV / EBITDA
8.7×
Historical Financials
APCOTEXIND · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹951 Cr | ₹1069 Cr | ₹1113 Cr | ₹1378 Cr | ₹1427 Cr | +10.7% |
| EBITDA | ₹147 Cr | ₹165 Cr | ₹121 Cr | ₹134 Cr | ₹194 Cr | +7.2% |
| EBIT | ₹134 Cr | ₹151 Cr | ₹90.1 Cr | — | — | -9.4% |
| PAT | ₹98.8 Cr | ₹108 Cr | ₹53.9 Cr | ₹54.1 Cr | ₹101 Cr | +0.7% |
| EPS (diluted) | ₹19.06 | ₹20.82 | ₹10.39 | — | — | -14.1% |
| CFO | ₹47.5 Cr | ₹121 Cr | ₹40.2 Cr | ₹84.7 Cr | ₹203 Cr | +43.8% |
| CapEx | ₹-68.0 Cr | ₹-187 Cr | ₹-27.8 Cr | ₹-50.0 Cr | ₹-44.5 Cr | — |
| FCF | ₹-20.4 Cr | ₹-65.6 Cr | ₹12.4 Cr | ₹34.8 Cr | ₹159 Cr | — |
| Total Assets | ₹605 Cr | ₹803 Cr | ₹922 Cr | ₹999 Cr | ₹986 Cr | +13.0% |
| Total Debt | ₹50.3 Cr | ₹152 Cr | ₹188 Cr | ₹189 Cr | ₹96.4 Cr | +17.7% |
| Shareholders' Equity | ₹396 Cr | ₹476 Cr | ₹522 Cr | ₹553 Cr | ₹621 Cr | +11.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
APCOTEXIND vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 NOCIL NOCIL | — | — | Pending | 3.1% | — |
 ROSSARI ROSSARI BIOTECH LIMITED | +0.2%+0.2% upside | 59 | Near Fair Value | 11.8% | — |
 POLYPLEX POLYPLEX | — | — | Pending | 3.4% | — |
TATVA TATVA | — | — | Pending | 0.8% | — |
 XPROINDIA XPROINDIA | — | — | Pending | 6.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
17 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹32.50/sh
Last payout
2026-06-12
₹5.50
Peak payout
₹5.50
Trailing yield
1.51%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. APCOTEX INDUSTRIES LIMITE (APCOTEXIND.NS) trades at 529.30 vs a model fair value of 388.65, a gap of -26.6%. Piotroski F-score: 8/9. Moat...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of APCOTEXIND →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for APCOTEXIND →
Compare
Head-to-head with peers
Compare APCOTEXIND side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse APCOTEXINDNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.